Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients

Status

Not yet recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06746571

Enrollment

100

Registered

2024-12-24

Start date

2025-01-15

Completion date

2026-01-15

Last updated

2024-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoblastic Leukemia

Brief summary

Role of cbc indices in acute lymphoblastic leukemia patients to explore the prognostic role of them in prediction the response to induction chemotherapy

Detailed description

Role of neutrophil to lymph ratio , lymphocyte to monocyte ratio and platelet to lymphocyte in acute lymphoblastic leukemia adults and pediatric patients to explore the prognostic role of them in prediction the response to induction chemotherapy

Interventions

DIAGNOSTIC_TESTcomplete blood count

measure cbc and blood ratios to compare their values with respone of patients to treatment

Study design

Allocation

Intervention model

CROSSOVER

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

5 Years to 50 Years

Healthy volunteers

Inclusion criteria

* patients newly diagnosed ALL

Exclusion criteria

* others malignanices * ALL on therapy

Design outcomes

Primary

Measure	Time frame	Description
neutrophil to lymphocyte ratio	1 year	count of neutophils comparing lymphocytees

Countries

Egypt

Contacts

Primary Contactomnia A Mohammed, resident

omnia_ali_post@med.sohag.edu.eg01121809920

Backup Contactheba a Ahmed, assistant professor

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026